Top Markets
Coin of the day
PLx Pharma Inc. PLx Pharma Inc.

PLx Pharma Inc.

PLXP
Classifica tra le azioni #41012
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Prezzo delle azioni
$0.00575
Ultima sincronizzazione: 2023-05-23
Capitalizzazione di mercato
$51.30K
Variazione (1 giorno)
-17.86%
Variazione (1 anno)
0.00%
Paese
US
Scambia PLx Pharma Inc. (PLXP)

Categoria

Storico del prezzo dell'azione per PLx Pharma Inc. (PLXP)
Prezzo di chiusura più alto: $0.01 il 2023-05-01

Prezzo di chiusura più basso: $91.66 il 2014-03-01
Storico del prezzo dell'azione di PLx Pharma Inc. dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -96.23%
2022 -97.44%
2021 49.84%
2020 28.85%
2019 56.87%
2018 -57.11%
2017 -45.00%
2016 -86.65%
2015 1.80%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$166.36 27.96%
DE
$36.27 22.59%
JP
$232.28 43.21%
CH
$21.32 13.71%
IN